W4V

General Information


DRACP ID  DRACP03930

Peptide Name   W4V

Sequence  RWRWWWRWRV

Sequence Length  10

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C84H109N27O11

Absent amino acids  ACDEFGHIKLMNPQSTY

Common amino acids  W

Mass  183366

Pl  12.98

Basic residues  4

Acidic residues  0

Hydrophobic residues  6

Net charge  4

Boman Index  -4399

Hydrophobicity  -183

Aliphatic Index  29

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  27500

Absorbance 280nm  3055.56

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 31687796

Title  Therapeutic Potential of Trp-Rich Engineered Amphiphiles by Single Hydrophobic Amino Acid End-Tagging

Doi Not available

Year  2019

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  14237

DRACP is developed by Dr.Zheng's team.